Mechanism of MPTP toxicity: more answers, more questions
- 1 January 1985
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 6, 375-378
- https://doi.org/10.1016/0165-6147(85)90176-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Biochemical and Biophysical Research Communications, 1985
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTPNeuroscience Letters, 1984
- 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Destroys Dopamine Neurons in Explants of Rat Embryo MesencephalonScience, 1984
- 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigraNeuroscience Letters, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979